Indo Us Bio-Tech Limited

Equities

INDOUS6

INE250Z01010

Biotechnology & Medical Research

Market Closed - Bombay S.E. 06:00:53 2024-05-22 am EDT 5-day change 1st Jan Change
218.4 INR +4.00% Intraday chart for Indo Us Bio-Tech Limited +1.20% -8.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Indo Us Bio-Tech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Indo US Signs MoU with Navsari Agricultural University for Seed Production, Hybrid Rice Marketing MT
Indo US Bio Tech Bags Contract for Supply of Hybrid Vegetable Seeds to Chhattisgarh, India MT
Indo US Bio Tech Limited Enters into Rate Contract with Chhattisgarh State Seed and Agriculture Development Corporation Limited CI
Indo US Bio-Tech to Issue Bonus Shares MT
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Indo Us Bio-Tech Limited Announces Change in Composition of Committees of the Board CI
Indo Us Bio-Tech Limited announced that it has received INR 61.0103 million in funding from Improwised Technologies Pvt. Ltd CI
US Bio-Tech Sells 98.5% Stake in Subsidiary Agripari E-Commerce MT
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Indo Us Bio-Tech Limited announced that it expects to receive INR 27.0855 million in funding CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Indo Us Bio-Tech Limited Declares Dividend CI
Indo Us Bio-Tech Limited Recommends Dividend CI
Indo Us Bio-Tech Limited Announces Resignation of Samarth Patel, Non- Executive and Independent Director CI
976,000 Equity Shares of Indo Us Bio-Tech Limited are subject to a Lock-Up Agreement Ending on 14-MAY-2021. CI
Indo Us Bio-Tech Limited Announces Resignation of Nidhi Ajudia as Non- Executive and Independent Director CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2020 CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Full Year Ended March 31, 2020 CI
Indo Us Bio-Tech Limited Announces Appointment of Dimpy Joshi as Company Secretary and Compliance Officer CI
Indo Us Bio-Tech Limited Announces Board Appointments CI
Indo Us Bio-Tech Limited Reports Earnings Results for the Half Year Ended September 30, 2019 CI
Indo US Bio-Tech Limited Announces Board Resignations CI
Indo Us Bio-Tech Limited Approves Resignation of Sangeeta Dilipkumar Narwani as Company Secretary and Compliance Officer CI
Chart Indo Us Bio-Tech Limited
More charts
Indo US Bio-Tech Limited is engaged in research and development throw breeding, production of seeds, processing, packing and marketing of hybrid and open pollinated varieties of agricultural crops. It is also engaged in educating the local farmers by demonstration of various cultivated research crops. Its product portfolio includes a diversified variety of agriculture seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, cumin, coriander and others. It has a distribution network in the state of Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Rajasthan, Himanchal Pradesh, Punjab, Bihar, Uttar Pradesh, Karnataka, Jharkhand and others. It also exports to many countries, namely the United States, New Jersey, Palestine, Maimi USA, Cameroon, Kuwait, Sri Lanka and Mauritius.
More about the company
  1. Stock Market
  2. Equities
  3. INDOUS6 Stock
  4. News Indo Us Bio-Tech Limited
  5. Indo US Bio Tech Bags Contract for Supply of Hybrid Vegetable Seeds to Chhattisgarh, India